A “micro-tap” for treating glaucoma

Share via AddThis
Posted March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL



51,365 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)


New algorithm improves speed and accuracy of pedestrian detection
What if computers could recognize objects as well as the human brain could? Electrical engineers at the University…

Featured Image (see all)


NASA’s James Webb Space Telescope Primary Mirror Fully Assembled
The 18th and final primary mirror segment is installed on what will be the biggest and most powerful…